Resistance Training for Cardiovascular Disease

Author(s):  
Randy Braith ◽  
Joseph Avery
2012 ◽  
Vol 44 (3) ◽  
pp. 525-533 ◽  
Author(s):  
LYNDSEY M. HORNBUCKLE ◽  
PEI-YANG LIU ◽  
JASMINKA Z. ILICH ◽  
JEONG-SU KIM ◽  
BAHRAM H. ARJMANDI ◽  
...  

2018 ◽  
Vol 48 (12) ◽  
pp. 2785-2795 ◽  
Author(s):  
William Evans ◽  
Quentin Willey ◽  
Erik D. Hanson ◽  
Lee Stoner

2008 ◽  
Vol 2 (2) ◽  
pp. 115-121 ◽  
Author(s):  
Naga Meka ◽  
Srikanth Katragadda ◽  
Biju Cherian ◽  
Rohit R. Arora

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Brandon Stuwart Shaw ◽  
Stacey Turner ◽  
Ina Shaw

Background: Cardiovascular disease (CVD) exemplifies a major medical problem as it is the most considerable cause of morbidity and mortality. While sport conditioning specialists understand and differentiate the different benefits of resistance training (RT) subtypes on athletic performance, this distinction is less clear for health professionals when designing CVD risk reduction programs. Objectives: This study attempted to investigate and compare the effects of hypertrophy and muscular endurance RT on CVD risk in sedentary males. Methods: Sedentary male smokers were randomly assigned to either an eight-week hypertrophy RT group (HTG) (n = 15), muscular endurance RT groups (METG) (n = 15), or a non-exercising control group (CON) (n = 15) to assess their impact on smoking, blood pressure, cholesterol, and cardiorespiratory fitness (VO2max) variables associated with the four most prominent CVD risk factors. Data were analyzed using SPSS-25 software using a paired sample t-test and ANOVA. Results: Significant (P ≤ 0.05) improvements were found in three of the 15 measured variables in the HTG (resting mean arterial pressure (RMAP) (P = 0.024); total cholesterol (TC): HDL-C ratio (P = 0.009), and HDL-C: low-density lipoprotein cholesterol (LDL-C) ratio (P = 0.038), with a deleterious decrease in high-density lipoprotein cholesterol (HDL-C) (P = 0.027). In turn, significant improvements were found in the METG in 10 of the 15 measured variables, namely; cigarettes smoked per day (P = 0.037), resting systolic blood pressure (RSBP) (P = 0.002), resting diastolic blood pressure (RDBP) (P = 0.006), RMAP (P = 0.000), TC (P = 0.010), triglycerides (TG) (P = 0.010), LDL-C (P = 0.007), HDL-C: LDL-C (P = 0.018), non-HDL-C (n-HDL-C) (P = 0.010), and VO2max (P = 0.001), and a deleterious decrease in HDL-C (P = 0.026). Conclusions: While the oversimplification of RT design for CVD reduction has resulted in cardio-centric CVD training programs, this study demonstrates that some subtypes of RT (i.e. muscular endurance training) may prove more useful than others in reducing multiple CVD risk factors simultaneously.


2021 ◽  
Author(s):  
Brandon S. Shaw ◽  
Gregory A. Brown ◽  
Ina Shaw

Contrary to the longstanding taboo of resistance training (RT) as a therapeutic treatment, RT has been gaining importance as a safe therapeutic option in the management of numerous diseases. Although exercise has well-documented health benefits on cardiovascular disease (CVD), the benefit of RT on CVD risk factors is not yet as widely prescribed as other modes of exercise. Due to its efficacy in the management of CVD, RT should be regarded as a complementary therapeutic treatment rather than a substitute to other modes of exercise therapy. While it is clear that RT can result in an attenuation of CVD risk, the various RT design options related to intensity and volume and how they impact on CVD risk, especially in different populations (i.e. children, elderly, women) is not yet well documented. This chapter will discuss the physiological phenomenon and benefits of RT as a therapeutic intervention aiming to manage CVD risk.


2007 ◽  
Vol 39 (Supplement) ◽  
pp. S292
Author(s):  
Carol A. DeNysschen ◽  
Harold Burton ◽  
Peter Horvath ◽  
John Leddy ◽  
Richard Browne

Sign in / Sign up

Export Citation Format

Share Document